1 |
Allison RR, Mang TS, Wilson BD. Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies. Semin Cutan Med Surg 1998;17:153-163
DOI
ScienceOn
|
2 |
Dougherty TJ, Lawrence G, Kaufman JH, Boyle D, Weishaupt KR, Goldfarb A. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 1979;62:231-237
|
3 |
Runnels JM, Chen N, Ortel B, Kato D, Hasan T. BPDMA-mediated photosensitization in vitro and in vivo: cellular adhesion and beta1 integrin expression in ovarian cancer cells. Br J Cancer 1999;80:946-953
DOI
ScienceOn
|
4 |
Poste G, Kirsh R, Allison BA. Site-specific (targeted) drug delivery in cancer therapy. Bio/Technology 1983;1:869-878
DOI
|
5 |
Damoiseau X, Schuitmaker HJ, Lagerberg JWM, Hoebeke M. Increase of photosensitizing efficiency of the bacteriochlorin a by liposomes-incorporation. J Photoch Photobio B Biol 2001;60:50-60
DOI
ScienceOn
|
6 |
Isele U, Schieweck K, Kessler R, Hoogevest PV, Capraro HG. Pharmacokinetics and body distribution of liposomal zinc phthalocyanine in tumor-bearing mice: influence of aggregation state, particle size and composition. J Pharm Sci 1995;84:166-173
DOI
ScienceOn
|
7 |
Schroit AJ, Madsen J, Nayar R. Liposome-cell interactions; in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes. Chem Phys Lipids 1986;40:373-393
DOI
ScienceOn
|
8 |
Rensen PC, Love WG, Taylor PW. In vitro interaction of zinc (II)-phthalocyanine-containing liposomes and plasma lipoproteins. J Photochem Photobiol B 1994;26:29-35
DOI
ScienceOn
|
9 |
Renno RZ, Miller JW. Photosensitizer delivery for photodynamic therapy of choroidal neovascularization. Adv Drug Deliv Rev 2001;52:63-78
DOI
ScienceOn
|
10 |
Morgan AR, Garbo GM, Keck RW, Selman SH. New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors. Cancer Res 1988;48:194-198
|
11 |
Labib A, Lenaerts V, Chouinard F, Leroux JC, Ouellet R, Van Lier JE. Biodegradable nanospheres containing phthalocyanines and naphthalocyanines for targeted photodynamic tumor therapy. Pharm Res 1991;8:1027-1031
DOI
ScienceOn
|
12 |
Allemann E, Brasseur N, Benrezzak O, et al. PEG-coated poly (lactic acid) nanoparticels for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours. J Pharm Pharmacol 1995;47:382-387
DOI
ScienceOn
|
13 |
Bachor R, Shea CR, Belmonte SJ, Hasan T. Free and conjugated chlorin e6 in the photodynamic therapy of human bladder carcinoma cells. J Urol 1991;146:1654-1658
DOI
|
14 |
Bachor R, Shea CR, Gilles R, Hasan T. Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres. Proc Natl Acad Sci USA 1991;88:1580-1584
DOI
|
15 |
Candide C, Morliere P, Goldstein S, et al. In vitro interaction of the photoactive anticancer porphyrin derivate photofrin II with low density lipoprotein, and its delivery to cultured human fibroblasts. FEBS Lett 1986;207:133-138
DOI
ScienceOn
|
16 |
Taillefer J, Brasseur N, van Lier JE, Lenaerts V, Le Garrec D, Leroux JC. In-vitro and in-vivo evaluation of pH-responsive polymeric micelles in a photodynamic cancer therapy model. J Pharm Pharmacol 2001;53:155-166
DOI
ScienceOn
|
17 |
Akhlynina TV, Rosenkranz AA, Jans DA, Sobolev AS. Insulin- mediated intracellular targeting enhances the photodynamic activity of chlorin e6. Cancer Res 1995;55:1014-1019
|
18 |
van Berkel TJC. Drug targeting: application of endogenous carriers for site-specific delivery of drugs. J Control Release 1993;24:145-155
DOI
|
19 |
Schmidt-Erfurth U, Diddens H, Birngruber R, Hasan T. Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br J Cancer 1997;75:54-61
DOI
ScienceOn
|
20 |
Klyashchitsky BA, Nechaeva IS, Ponomaryov GV. Approaches to targeted photodynamic tumor therapy. J Control Releas 1994;29:1-16
DOI
|
21 |
Illum L, Jones PDE. Attachment of monoclonal antibodies to microspheres. Methods Enzymol 1985;112:67-84
DOI
|
22 |
Oseroff AR, Ara G, Ohuoha D, et al. Strategies for selective cancer photochemotherapy: antibody-targeted and selective carcinoma cell photolysis. Photochem Photobiol 1987;46:83-96
DOI
ScienceOn
|
23 |
Oseroff AR, Ohuoda D, Hasan T, Bommer JC. Antibodytargeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugate. Proc Natl Acad Sci USA 1986;83:8744-8748
DOI
ScienceOn
|
24 |
Jiang FN, Jiang S, Liu D, Ritcher A, Levy JG. Development of technology for linking photosensitizers to a model monoclonal antibody. J Immunol Methods 1990;134:139-149
DOI
ScienceOn
|
25 |
Kessel D, Morgan A, Garbo GM. Sites and efficacy of photodamage by tin etiopurpurin in vitro using different delivery systems. Photochem Photobiol 1991;54:193-196
DOI
ScienceOn
|
26 |
Hioka N, Chowdhary RK, Chansarkar N, Delmarre D, Sternberg E, Dolphin D. Studies of benzoporphyrin derivative with Pluronics. Can J Chem 2002;80:1321-1326
DOI
ScienceOn
|
27 |
Segalla A, Milanesi C, Capraro HG, Isele U, Schieweck K. CGP 55398, a liposomal Ge (IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours. Br J Cancer 1994;69:817-825
DOI
ScienceOn
|
28 |
Geze M, Morliere P, Maziere JC, Smith KM, Santus R. Lysosomes, a key target of hydrophobic photosensitizers proposed for photochemotherapeutic applications. J Photoch Photobio B 1993;20:23-35
DOI
ScienceOn
|
29 |
Jori G, Reddi E, Cozzani I, Tomio L. Controlled targeting of different subcellular sites by porphyrin in tumour-bearing mice. Br J Cancer 1986;53:615-621
DOI
ScienceOn
|
30 |
Mew D, Wat CK, Towers GHN, Levy JG. Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J Immunol 1983;130:1473-1477
|
31 |
Allison BA, Crespo MT, Jain AK, Richter AM, Hsiang YS, Levy JG. Delivery of benzoporphyrin derivate, a photosensitizer, into atherosclerotic plaque of watanabe heritable hyperlipidemic rabbits and balloon-injured New Zealand rabbits. Photochem Photobiol 1997;65:877-883
DOI
ScienceOn
|
32 |
Westermann R, Glanzmann T, Andrejevie S, et al. Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in mice grafted with a human colon carcinoma. Int J Cancer 1998;76:842-850
DOI
ScienceOn
|
33 |
Zhang JX, Hansen CB, Allen TM, Boey A, Boch R. Lipidderivatized poly (ethylene glycol) micellar formulations of benzoporphyrin derivatives. J Control Release 2003;86:323-338
DOI
|
34 |
Allison RR, Downie GH, Cuenca R, Hu XH, Childs CJH, Sibata CH. Photosensitizers in clinical PDT. Photodiag Photodyn Therapy 2004;1:27-42
DOI
ScienceOn
|
35 |
Nakanishi T, Fukushima S, Okamoto K, et al. Development of the polymer micelle carrier system for doxorubicin. J Control Release 2001;74:295-302
DOI
ScienceOn
|
36 |
Taillefer J, MC Jones, Brasseur N, van Lier JE, Leroux JC. Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs. J Pharm Sci 2000;89:52-62
DOI
ScienceOn
|
37 |
Lutsenko SV, Feldman NB, Finakova GV, et al. Targeting phthalocyanines to tumor cells using epidermal growth factor conjugates, Tumour Biol 1999;20:218-224
DOI
ScienceOn
|
38 |
Allison BA, Waterfield E, Richter AM, Levy JG. The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem Photobiol 1991;54:709-715
DOI
ScienceOn
|
39 |
Sharman WM, van Lier JE, Allen CM. Targeted photodynamic therapy via receptor mediated delivery systems. Adv Drug Delivery Rev 2004;56:53-76
DOI
ScienceOn
|
40 |
Morgan J, Gray AG, Huehns ER. Specific targeting and toxicity of sulphonated aluminum phthalocyanine photosensitized liposomes directed to cells by monoclonal antibody in vitro. Br J Cancer 1989;59:366-370
DOI
ScienceOn
|
41 |
Richter AM, Waterfield E, Jain AK, Canaan JA, Allison BA, Levy JG. Liposomal delivery of a photosensitizer benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem Photobiol 1993;57:1000-1006
DOI
ScienceOn
|
42 |
Keene JP, Kessel D, Land EJ, Redmond RW, Truscott TG. Direct detection of singlet oxygen sensitized by haematoporphyrin and related compounds. Photochem Photobiol 1986;43:117-120
DOI
ScienceOn
|
43 |
Selman SH, Garbo GM, Keck RW, Kreimer-Birnbaum M, Morgan AR. A dose responsive analysis of purpurin derivatives used as photosensitizers for the photodynamic treatment of transplantable fanft induced urothelial tumors. J Urol 1987;137:1255-1257
DOI
|
44 |
Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci 2003;92:1343-1355
DOI
ScienceOn
|
45 |
Barel A, Jori G, Perin A, Romandini P, Pagnan A, Biffanti S. Role of high, low-and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo. Cancer Lett 1986;32:145-150
DOI
ScienceOn
|
46 |
Hamblin MR, Newman EL. Photosensitizer targeting in photodynamic thearpy I. Conjugates of haematoporphyrin with albumin and transferrin. J Photochem Photobiol B 1994;26:45-46
DOI
ScienceOn
|
47 |
Mew D, Lum V, Wat CK, et al. Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selective cell lines subsequent to light activation. Cancer Res 1985;45:4380-4386
|
48 |
Daniell MD, Hill JS. A history of photodynamic therapy. Aust NZ J Surg 1991;61:340-348
DOI
|
49 |
Detty MR, Gibson SL, Wagner SJ. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 2004;47;3897-3915
DOI
ScienceOn
|
50 |
Wilson BC, Olivo M, Singh G. Subcellular localization of photofrin and aminolevulinic acid and photodynamic crossresistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodyanamic therapy. Photochem Photobiol 1997;65:166-176
DOI
ScienceOn
|
51 |
Parrish JA, Fitzpatrick TB, Tanenbaum L, et al. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974;291:1207-1211
DOI
ScienceOn
|
52 |
Reddi E, Zhou C, Biolo R, Menegaldo E, Jori G. Liposome or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumors. I. Pharmacokinetic properties and phototherapeutic efficiency. Br J Cancer 1990;61:407-411
DOI
ScienceOn
|
53 |
Moan J, Peng Q. An outline of the hundred-year history of PDT. Anticancer Res 2003;23:3591-3600
|
54 |
Jori G, Beltramini M, Reddi E, et al. Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. Cancer Lett 1984;24:291-297
DOI
ScienceOn
|
55 |
Vrouenraets MB, Visser GWM, Loup C, et al. Targeting of a hydrophilic photosensitizer by use on internalizing monoclonal antibodies: a new possibility for use in photodynamic therapy. Int J Cancer 2000;88:108-114
DOI
ScienceOn
|
56 |
Steyger PS, Baban DF, Brereton M, Ulbrich K, Seymour LW. Intratumoral distribution as a determinant of tumour responsiveness to therapy using polymer-based macromolecular prodrug. J Control Release 1996;39:35-46
DOI
ScienceOn
|
57 |
Brasseur N, Ouellet R, La Madeleine C, Van Lier JE. Water soluble aluminum phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice. Br J Cancer 1999;80:1533-1541
DOI
ScienceOn
|
58 |
Bellemo C, Jori G, Rihter BD, Kenney ME, Rodgers MAJ. Si (IV)naphtahlocyanine: modulation of its pharmacokinetic properties through the use of hydrophilic axial ligands. Cancer Lett 1992;65:145-150
DOI
ScienceOn
|
59 |
Hasan T, Lin A, Yarmush D, Oseroff A, Yarmush M. Monoclonal antibody-chromophore conjugate as selective phototoxins. J Control Release 1989;10:107-117
DOI
ScienceOn
|
60 |
Bos E, Boon P, Kaspersen F, McCabe R. Passive immunotherapy of cancer: perspectives and problems. J Control Release 1991;16:101-112
DOI
ScienceOn
|
61 |
Nagata S, Obana A, Gohto Y, Nakajima S. Necrotic and apoptotic cell death of human malignant melanoma cells following photodynamic therapy using an amphiphilic photosensitizer ATX-S10(Na). Laser Surg Med 2003;33:64-70
DOI
ScienceOn
|
62 |
Vemuri S, Rhodes CT. Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharm Acta Helv 1995;70:95-111
DOI
ScienceOn
|
63 |
Lasic DD, Martin FJ, Gabizon A, Huang SK, Papahadjopoulos D. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation time. Biochim Biophys Acta 1991;1070:187-192
DOI
ScienceOn
|
64 |
Gijsens A, Witte P. Phototoxic action of EGF-PVA-Sn (IV) chlorin e6 and EGF-dextran-Sn (IV)chlorin e6 internalizable conjugates on A431 cells. Int J Cancer 1998;13:1171-1177
|
65 |
Allison BA, Pritchard PH, Levy JG. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative. Br J Cancer 1994;69:833-839
DOI
ScienceOn
|
66 |
Lipson RL, Baldes EJ. Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease. J Thorac Cardiovasc Surg 1961;42:623-629
|
67 |
Berg K, Prasmickaite L, Selbo PK, Hellum M, Bonsted A, Hogset A. Photochemical internalization (PCI)-a novel technology for release of macromolecules from endocytic vesicles. Oftalmologia 2003;56:67-71
|
68 |
Chung JE, Yokoyama M, Yamato M, Aoyagi T, Sakurai Y, Okano T. Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly (N-isopropylacryladmide) and poly (butylmethacrylate). J Control Release 1999;62:115-127
DOI
|
69 |
Hamblin MR, Del Gorvernatore M, Rizvi I, Hasan T. Biodistribution of charged 17.4A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br J Cancer 2000;83:1544-1551
DOI
ScienceOn
|
70 |
Juliano RL. Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions. Adv Drug Deliv Rev 1988;2:31-54
DOI
ScienceOn
|
71 |
Kulkarni SR, Korgaonkar CK. Photodynamic therapy: a novel approach to treat variety of diseases. Indian Drugs 1996;33:487-495
|
72 |
Maruyama K, Ishida O, Takizama T, Moribe K. Possibility of active targeting to tumor tissues with liposomes. Adv Drug Deliv Rev 1999;40:89-102
DOI
|
73 |
Yasugi K, Nagasaki Y, Kato M, Kataoka K. Preparation and characterization of polymer micelles from poly (ethylene glycol)-poly (D,L-lactide) block copolymers as potential drug carrier. J Control Release 1999;62:89-100
DOI
ScienceOn
|
74 |
Kwon G, Suwa S, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly (ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J Control Release 1994;29:17-23
DOI
|
75 |
Sharman WM, Allen CM, van Lier JE. Role of activate oxygen species in photodynamic therapy. Methods Enzymol 2000;319:376-400
DOI
|
76 |
Schmidt-Erfurth U, Hasan T, Gragoudas ES, Michaud N, Flotte TJ, Birngruber R. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 1994;101:1953-1961
DOI
|
77 |
Le Garrec D, Taillefer J, van Lier JE, Lenaerts V, Leroux JC. Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model. J Drug Target 2002;10:429-437
DOI
ScienceOn
|
78 |
Duska LR, Hamblin MR, Bamberg MP, Hasan T. Biodistribution of charged F (ab') 2 photoimmuno-conjugates in a xenograft model of ovarian cancer. Br J Cancer 1997;75:837-844
DOI
ScienceOn
|
79 |
Liu D, Huang L. Immunoliposome targeting to pulmonary endothelium. In: Gregoriadis G, Florence AT, Patel HM, eds. Liposomes in drug delivery. 1st ed. Switzerland: Harwood Academic Publishers, 1993:111-121
|
80 |
Dummin H, Cernay T, Zimmermann HW. Selective photosensitization of mitochondria in HeLa cells by cationic Zn (II) phthalocyanines with lipophilic side-chains. J Photoch Photobio B 1997;37:219-229
DOI
ScienceOn
|
81 |
Konan YN, Gurny R, Allemann E. State of art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B 2002;66:89-106
DOI
ScienceOn
|
82 |
Tijerina M, Foweres KD, Kopeckova P, Kopecek J. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce p-glycoprotein-mediated multidrug resistance. Biomaterials 2000;21:2203-2210
DOI
ScienceOn
|
83 |
Hynds SA, Welsh J, Stewart JM, et al. Low-density lipoprotein metabolism mice with soft tissue tumours. Biochim Biophys Acta 1984;794:589-595
|
84 |
Dougherty TJ, Grindey GB, Fiel R, Weishaupt KR, Boyle DG. Photoradiation therapy II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 1975;55:115-121
DOI
|
85 |
Morgan J, Oseroff AR. Mitochondria-based photodynamic anti-cancer therapy. Adv Drug Deliv Rev 2001;49:71-86
DOI
|
86 |
Teiten MH, Bezdetnaya L, Morliere P, Santus R, Guillemin F. Endoplasmic reticulum and golgi apparatus are the preferential sites of Foscan localization in cultured tumour cells. Br J Cancer 2003;88:146-152
DOI
|
87 |
Worle D, Muller S, Shopova M, et al. Effect of delivery system on the pharmacokinetic and phototherapeutic properties of bis (methyloxyethyleneoxy) silicon-phthalocyanine in tumor-bearing mice. J Photochem Photobiol B 1999;50:124-128
DOI
|
88 |
Michaud LB. Methods for preventing reactions secondary to cremophor EL. Ann Pharmacother 1997;31:1402-1404
DOI
|
89 |
Aveline BM, Redmond RW. Can cellular phototoxicity be accurately predicted on the basis of sensitizer photophysics? Photochem Photobiol 1999;69:306-316
DOI
ScienceOn
|
90 |
Takeuchi Y, Kurohane K, Ichikawa K, Yonezawa S, Nango M, Oku N. Induction of intensive tumor suppression by antiangiogenic photodyanamic therapy using polycation-modified liposomal photosensitizer. Cancer 2003;97:2027-2034
DOI
ScienceOn
|
91 |
Jiang FN, Allison B, Liu D, Levy JG. Enhanced photodynamic killing of target cells by either monoclonal antibody or low density lipoprotein mediated delivery systems. J Control Release 1992;19:41-58
DOI
ScienceOn
|
92 |
Del Gorvernatore M, Hamblin MR, Piccinini EE, Ugolini G, Hasan T. Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates. Br J Cancer 2000;82:56-64
DOI
ScienceOn
|
93 |
MacDonald IJ, Morgan J, Bellnier DA, et al. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives. Photochem Photobiol 1999;70:789-797
DOI
ScienceOn
|
94 |
Allison RR, Mota HC, Sibata CH. Clinical PD/PDT in north America: an historical review. Photodiag Photodyn Ther 2004;1:263-277
DOI
ScienceOn
|